Inhaled cocaine used to relieve "off" periods in patients with Parkinson disease and unpredictable motor fluctuations: A report of 2 cases [15]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 6, 2006, Pages 689-690

  Di Rocco, Alessandro ^a   Nasser, Sabina ^b   Werner, Peter ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Graduate School of Humanities and Social Sciences   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; APOMORPHINE; CARBIDOPA PLUS LEVODOPA; COCAINE; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; SELEGILINE;

ADULT; ANAMNESIS; ANXIETY; CASE REPORT; DRUG TOLERANCE; DYSKINESIA; FEMALE; HUMAN; LETTER; MALAISE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; PARKINSON DISEASE; PRIORITY JOURNAL; SIDE EFFECT; TREMOR; WALKING DIFFICULTY;

ADMINISTRATION, INHALATION; COCAINE; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MIDDLE AGED; PARKINSON DISEASE; SELF MEDICATION;

EID: 33751080752     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000245564.44778.d1     Document Type: Letter

References (9)

1. Yahr MD. Parkinson's disease. The L-dopa era. Adv Neurol. 1993;60:11-17.
2. Kahlig KM, Galli A. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur J Phamacol. 2003;479:153-158.
3. Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci. 2003;4(1):13-25.
4. Gainetdinov RR, Caron MG. Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol. 2003;43:261-284.
5. Sora I, Hall FS, Andrews AM, et al. Molecular mechanisms of cocaine reward: combined DA and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A. 2001;98(9):5300-5305.
6. Miller E, Nieburg HA. Amphetamines, valuable adjunct in treatment of parkinsonism. N Y State J Med. 1973;73:2657-2661.
7. Nutt DJ, French N, Handley S, et al. Functional studies of specific imidazoline-2 receptor ligands. Ann N Y Acad Sci. 1995;763:125-139.
8. Nutt JG, Carter JH, Sexton GJ. The dopamine transporter: importance in Parkinson's disease. Ann Neurol. 2004;55(6):766-773.
9. Mash DC, Ouyang Q, Pablo J, et al. Cocaine abusers have an over-expression of alpha-synuclein in dopamine neurons. J Neurosci. 2003;23(8):3531-3537.